Bridgeway Capital Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bridgeway Capital Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-154,908	Closed	-$200K	–	1460
2017 Q2	$200K	Sell	154,908 -26,292	-15%	-$37.3K	﹤0.01%	1292
2017 Q1	$353K	Hold	181,200	–	–	﹤0.01%	1168
2016 Q4	$388K	Hold	181,200	–	–	0.01%	1170
2016 Q3	$312K	Hold	181,200	–	–	﹤0.01%	1234
2016 Q2	$149K	Hold	181,200	–	–	﹤0.01%	1351
2016 Q1	$163K	Hold	181,200	–	–	﹤0.01%	1333
2015 Q4	$199K	Buy	181,200 +100,600	+125%	+$215K	﹤0.01%	1303
2015 Q3	$170K	Hold	80,600	–	–	﹤0.01%	1333
2015 Q2	$160K	Buy	+80,600	New	+$228K	﹤0.01%	1382
2014 Q4	–	Sell	-15,000	Closed	-$40K	–	1530
2014 Q3	$40K	Sell	15,000 -20,000	-57%	-$134K	﹤0.01%	1461
2014 Q2	$407K	Hold	35,000	–	–	0.01%	1179
2014 Q1	$489K	Buy	+35,000	New	+$550K	0.01%	1085

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Azimuth Capital Management Bloomfield Hills, Michigan $2.34B AUM 16.67% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bridgeway Capital Management's MBII Position: Q3 2017 in Review

Bridgeway Capital Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2017, closing a stake of 154,908 shares — an estimated $200K sold.

Bridgeway Capital Management first reported a position in MBII in Q1 2014 and held it in 12 quarters. The position peaked at $489K in Q1 2014. 23 funds tracked by Wall St. Rank hold MBII as of Q3 2017.

Bridgeway Capital Management reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2017 after selling out during the quarter.
Bridgeway Capital Management sold 154,908 Marrone Bio Innovations, Inc. shares in Q3 2017, an estimated $200K.
Bridgeway Capital Management first reported a position in Marrone Bio Innovations, Inc. in Q1 2014 and held it in 12 quarters.
Bridgeway Capital Management's Marrone Bio Innovations, Inc. position peaked at $489K in Q1 2014.
23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2017.

Based on Bridgeway Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.